Axsome Therapeutics shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Rhenman & Partners Asset Management AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $21M | 173k | 121.45 |
| 2025-06-30 | $9.5M | 91k | 104.39 |
| 2025-03-31 | $13M | 110k | 116.63 |
| 2024-12-31 | $10M | 123k | 84.61 |
| 2024-09-30 | $11M | 123k | 89.87 |
| 2024-06-30 | $10M | 128k | 80.50 |
| 2024-03-31 | $12M | 144k | 79.80 |
| 2023-09-30 | $2.8M | 40k | 69.89 |
| 2023-06-30 | $2.9M | 40k | 71.86 |
| 2023-03-31 | $908k | 15k | 60.55 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB